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Novel mouse models were developed in which 
the hepatic selenoprotein population was 
targeted for removal by disrupting the 
selenocysteine (Sec) tRNA[Ser]Sec gene (trsp) and 
then selenoprotein expression was restored by 
introducing wild type or mutant trsp 
transgenes. The selenoprotein population was 
partially replaced in liver with mutant 
transgenes encoding mutations at either 
position 34 (T34->A34) or 37 (A37->G37) in 
tRNA[Ser]Sec. The A34 transgene product lacked 
the highly modified 5-methoxycarbonylmethyl-
2’ O-methyluridine and its mutant base A was 
converted to I34. The G37 transgene product 
lacked the highly modified N6-
isopentenyladenosine. Both mutant tRNAs 
lacked the 2’-methylribose at position 34 
(Um34), and both supported expression of 
housekeeping selenoproteins (e.g., thioredoxin 
reductase 1) in liver, but not stress-related 
proteins (e.g., glutathione peroxidase 1). Thus, 
Um34 is responsible for synthesis of a select 
group of selenoproteins rather than the entire 
selenoprotein population. The ICA anticodon in 
the A34 mutant tRNA decoded Cys codons, 
UGU and UGC, as well as the Sec codon, UGA. 
However, metabolic labeling of A34 transgenic 
mice with 75Se revealed that selenoproteins 
incorporated the label from the A34 mutant 
tRNA, whereas other proteins did not.  These 
results suggest that the A34 mutant tRNA did 
not randomly insert Sec in place of Cys, but 
specifically targeted selected selenoproteins. 
High copy numbers of A34 transgene, but not 
G37 transgene, were not tolerated in the 
absence of wild type trsp further suggesting 
insertion of Sec in place of Cys in 
selenoproteins.  
 
     There are 24 known selenoproteins in rodents 
and 25 in humans (1). The targeted removal of 
specific selenoproteins has shown that some are 
essential in development whereas others appear to 
be non-essential. For example, the loss of 
selenoproteins glutathione peroxidase 4 (GPx4; 2), 
or thioredoxin reductase 1 (TR1 or Txnrd1; 3) or 2 
(TR3 or Txnrd2; 4) is embryonic lethal, while the 
loss of glutathione peroxidase 1 (GPx1; 5) or 2 
(GPx2; 6) appears to be of little or no 
consequence. Other studies, however, suggest that 
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those selenoproteins whose loss results in little or 
no phenotypic change may function in protective 
mechanisms against certain environmental stresses 
(see 6 and references therein). There are 
selenoproteins whose removal or mutation results 
in dramatic effects on health. For example, 
knockout of selenoprotein P (SelP) causes 
neurological problems (7,8) and knockout of type 
2 iodothyronine deiodinase results in a variety of 
defects including an impaired adaptive 
thermogenesis and hypothermia in cold-exposed 
mice (see 9 and references therein), retarded 
cochlear development and hearing loss (10) and a 
pituitary resistance to T4 (11). Mutations affecting 
selenoprotein N (SelN) result in several muscle 
disorders (12,13). 
     LoxP-Cre technology, which allows the 
removal of embryonic lethal genes in specific 
tissues and organs (3,4,14), has been used to 
examine the roles of essential selenoprotein genes 
in development and health. Such studies have 
elucidated key roles of TR1 in embryogenesis of 
numerous tissues and organs, except heart (3), and 
of TR3 in hematopoiesis and in heart development 
and function (4). The targeted removal of the 
nuclear form of GPx4 (designated snGPx4) results 
in viable and completely fertile animals, although 
the overall structural stability of sperm chromatin 
is diminished (14). Loss of SelP in liver, achieved 
by targeted knockout of the selenocysteine (Sec) 
tRNA[Ser]Sec gene (designated trsp), implicated 
SelP in transport functions in plasma, and 
substantiated its essential role in brain (15). 
     Selenoprotein synthesis is dependent on the 
presence of Sec tRNA[Ser]Sec. Given this 
dependence, selenoprotein expression can be 
modulated by perturbing Sec tRNA[Ser]Sec 
expression, providing a means of elucidating the 
role of selenoproteins and selenium in 
development and health (16). The Sec tRNA[Ser]Sec 
population in higher vertebrates consists of two 
isoforms that differ by a single 2’O-methyl group.  
One isoform contains 5-
methoxycarbonylmethyluridine (mcm5U) at 
position 34 and the other is methylated on the 
ribosyl moiety at that position generating 5-
methoxycarbonylmethyl-2’O-methyluridine 
(mcm5Um; 17). The presence of this 2’-methyl 
ribose modification (designated Um34) confers 
several unique properties on mcm5Um. For 
example, Um34 affects Sec tRNA[Ser]SecmcmUm 
secondary and tertiary structure (18).  Um34 
addition is dependent on the prior synthesis of the 
four modified bases found in tRNA[Ser]Sec and on 
an intact tertiary structure (19). Synthesis of all 
other modified nucleosides of Sec tRNA[Ser]Sec, 
including mcm5U, is less stringently associated 
with primary and tertiary structure. In addition, 
synthesis of Um34 is dependent on the selenium 
status of the organism, with increased dietary 
selenium increasing Um34 levels (17).  
     Removal of trsp is embryonic lethal (20,21). 
Therefore, to alter the Sec tRNA[Ser]Sec population, 
techniques of influencing Sec tRNA[Ser]Sec levels 
other than the sole removal of trsp must be 
employed. We previously generated transgenic 
mice with extra copies of wild type or mutant Sec 
tRNA[Ser]Sec transgenes (22), and mice with a 
conditional knockout of trsp (21), and then 
rescued selenoprotein expression in trsp null mice 
with wild type or mutant Sec tRNA[Ser]Sec 
transgenes (23,24). Consistent with reports that the 
Sec tRNA[Ser]Sec population is not limiting in 
selenoprotein biosynthesis (20,22,25), we found 
little or no effect of extra copies of wildtype 
transgenes on selenoprotein expression in the 
tissues and cells examined (22). In contrast, 
multiple copies of a mutant trsp transgene can lead 
to specific altercations in the selenoprotein 
population (22). For example, transgenes with a 
mutation at position 37 (A37->G37) produce a 
tRNA gene product that not only lacks 
isopentenyladenosine (i6A) at this site, but also 
lacks Um34 (19). Selenoprotein synthesis was 
affected in mice carrying the G37 Sec tRNA[Ser]Sec 
transgene in a protein- and tissue-specific manner 
(22). Rescue of selenoprotein expression in trsp 
null mice with the G37 Sec tRNA[Ser]Sec transgene 
results in the recovery of housekeeping 
selenoproteins, while numerous stress-related 
selenoproteins that are non-essential to survival 
are either not rescued, or are poorly rescued 
(23,24).  
     Although the wild type and mutant trsp 
transgenic models and transgenic-trsp rescue 
models have provided considerable insight into 
selenoprotein expression and the hierarchy of 
selenoprotein expression (21-24), they have 
limitations. For example, when expressing mutant 
trsp transgenes in mice carrying the endogenous 
allele of trsp, expression from the wildtype trsp 
can confound the studies. Studies with rescue 
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models like that described above, with a germline 
conditional trsp allele, focus on the selenoprotein 
population in the whole animal. The targeted 
removal of floxed trsp in defined cell types using 
transgenic mice with tissue-specific expression of 
Cre recombinase permitted some study of the 
effects of selenoprotein loss in specific tissues and 
organs in the absence of endogenous trsp.  
However,  the resulting animals have a variety of 
defects including embryonic mortality or early 
adult death (26) restricting the use of these models 
for studying the role of selenium and 
selenoproteins in health.  
     In the present study, we generated a mouse 
model that targets the removal of trsp in liver for 
use in elucidating the role of selenium and 
selenoproteins and the contributions of 
housekeeping and stress-related selenoproteins in 
health. trsp loxP-albumin Cre mice (27) were 
crossed with i6A-Um34 deficient Sec tRNA[Ser]Sec 
transgenic mice (designated herein as G37 
transgenic mice; (22)) or with another mutant trsp 
(T34->A34) transgenic mouse described herein 
that lacks mcm5U and consequently the Um34 
modification (designated herein as A34 transgenic 
mice). The resulting mouse lines lacks trsp in liver 
and are dependent on the A34 mutant transgene or 
the G37 mutant transgene for selenoprotein 
expression. These new mouse models provide us 
with novel experimental systems for investigating 
the role of numerous stress-related selenoproteins 
in health in a specifically targeted organ. 
 
EXPERIMENTAL PROCEDURES 
 
Materials - 75Se-selenium (specific activity 1000 
Ci/mmol) was obtained from the Research Reactor 
Facility, University of Missouri, Columbia, MO, 
3H-serine (specific activity 29 Ci/mmol) from 
Amersham and 32P-α-dCTP (specific activity 
~6000 Ci/mmol) from Perkin Elmer. Hybond 
Nylon N+ membranes were purchased from 
Amersham, NuPage 10% polyacrylamide gels, 
polyvinylidene difluoride (PVDF) membranes, 
Superscript II reverse transcriptase and SeeBlue 
Plus2 protein markers from Invitrogen, 
SuperSignal West Dura Extended Duration 
Substrate from Pierce, Universal Reference RNA 
from Stratagene, ADP Sepharose 4B resin from 
GE Healthcare and anti-rabbit-HRP and anti-
chicken-HRP conjugated secondary antibodies 
from Sigma. Reagents for the TR1 assay (22) were 
purchased from Sigma Aldrich. Antibodies against 
GPx1 were obtained from Abcam and antibodies 
against GPx4, TR1, TR3, SelR, and SelT were 
from our laboratories (1,24,27). All other reagents 
were obtained commercially and were products of 
the highest grade available. 
Animals and genotyping of mice – Homozygous 
floxed trsp C57BL/6 mice (trspfl) that were also 
homozygous for albumin Cre (AlbCre) were 
designated Δtrsp after trspfl was removed by the 
Cre recombinase (23,24,27). Δtrsp C57BL/6-
FVB/N transgenic mice were homozygous for one 
of three types of trsp transgene (trspt) alleles as 
follows: 1) wild type transgene encoding 10 copies 
of wild type trspt/allele (22); 2) G37 low or high 
copy transgene encoding either 1 (low) or 8 (high) 
copies of the A37->G37 mutant trspt/allele; or 3) 
A34 transgene encoding one copy of the T34->A34 
mutant trspt/allele. The product of the G37 
transgene lacks the highly modified base, i6A, at 
position 37 and also Um34. The single copy G37 
transgenic mouse was generated specifically for 
this study (22) to compare to the effects of the 
single copy A34 transgene. The product of the A34 
transgene lacked the highly modified base, 
mcm5U, and also lacked Um34. T34->A34 
transgenic mice were generated exactly as 
described (22) except that the transgene construct 
contained an A at position 34 instead of a T and 
the base at position 37 was the wild type A base; 
and three founders that were heterozygous for 1, 4 
and 6 transgene copies were obtained. A34 
transgenic mice were in strain FVB/N and 
founders were bred to obtain the corresponding 
homozygous mice (designated A34-2, A34-8 and 
A34-12, respectively).  
   Genotype designations and definitions are 
given in the legend of Table 1. All mice used in 
this study were males. Matings to obtain mouse 
lines carrying wild type, A34 and G37 transgenes 
and Δtrsp in their liver are summarized in Table 1. 
   Primers used for detecting trsp, trspfl, Δtrsp, 
trspt, G37 or A34 by PCR are designated CKNO2 
(forward primer) and RES1 and VP1 (reverse 
primers) (see Fig. 1 and ref 27). Primers used for 
detecting AlbCre are designated LIV1 (forward 
primer) and LIV2 (reverse primer) (see Fig. 1 and 
28 and references therein). The care of animals 
was in accordance with the National Institutes of 
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Health institutional guidelines under the expert 
direction of Dr. Kyle Stump (National Cancer 
Institute, National Institutes of Health, Bethesda, 
MD).   
  75Se-Labeling of selenoproteins - Mice were 
injected intraperitoneally with 50 μCi of 75Se/g 
and sacrificed 48 hrs after injection as described 
(see 23,27 and references therein). Tissues and 
organs were excised, immediately frozen in liquid 
nitrogen and stored at –80oC. Tissues were 
homogenized and 40 µg of protein were 
electrophoresed on NuPage 10% polyacrylamide 
gels. Gels were stained with Coomassie blue, dried 
and exposed to a PhosphorImager as described 
(23,27 and references therein). To further assess 
75Se-labeling of TR1, the labeled protein was 
purified from crude extracts of tissue using ADP 
Sepharose 4B prior to gel electrophoresis as 
described (22). TR3 is also enriched by the ADP-
Sepharose procedure, but the amounts of TR3 
relative to TR1 are only about 10% and likely not 
to influence overall levels of the TR population 
(e.g., in Fig. 3B). 
  Northern and Western blot analyses - Total RNA 
isolated from liver and kidney was analyzed by 
Northern blot hybridization using 32P-labeled 
probes. Membranes were analyzed with a 
PhosphorImager as described (23,27). Deiodinase-
1 (D1), GPx1, GPx4, SelK, SelP, SelR, SelW, 
Sep15, selenophosphate synthetase-2 (SPS2), and 
TR1 probes were used (23). The remaining probes 
were generated by RT-PCR using Superscript II 
reverse transcriptase and Universal Reference 
RNA or mouse liver RNA (23,27). 
     Protein extracts were prepared from liver and 
kidney and electrophoresed on NuPage 10% 
polyacrylamide gels.  Proteins were transferred to 
PVDF membranes as previously described with 
the exception that 40 μg of each protein extract 
were loaded onto gels (21-23,27) and 
immunoblotted with antibodies against GPx1 
(1:1000 dilution), GPx4 (1:2000), SelR (1:1000) 
and SelT (1:400). Anti-rabbit-HRP conjugated 
secondary antibody (1:30000) was used in all 
Western blots. Membranes were washed with 
0.1% TBS-T, incubated in SuperSignal West Dura 
Extended Duration Substrate and exposed to X-ray 
film. 
  GPx and TR1 activities and selenium assays - 
Total GPx activity was measured using a standard 
assay with hydrogen peroxide as substrate (23,27 
and references therein). TR1 activity was 
determined in cytosol-enriched protein extracts 
using the insulin reduction method (8). 
     The amount of selenium in extracts of liver, 
kidney, testes, brain and plasma was determined 
by Oscar E. Olsen Biochemistry Laboratories at 
South Dakota State University as described 
(23,27). 
  Isolation, aminoacylation, fractionation, and 
sequencing of tRNA and coding studies - Total 
tRNA was isolated from liver of each mouse line. 
The tRNA was aminoacylated with [3H]serine (29) 
and the resulting aminoacylated tRNA fractionated 
on a RPC-5 column (30) as described (22,23,27). 
Sec tRNAs that were synthesized intracellularly 
from the A34 mutant transgene encoding a base 
change were sequenced using an RT-PCR 
technique (31) in which individual fractions from 
the RPC-5 columns were used as designated in 
Fig. 6. Codon recognition studies were carried out 
on 3H-seryl-tRNA[Ser]Sec fractions from the RPC-5 
column using the ribosomal binding technique of 
Nirenberg and Leder (32) as described (29). 
Trinucleoside diphosphates AGA, GGA, CGA, 
UGA, UGU and UGC were the gift of Marshall 
Nirenberg or were prepared as described (29). 
 
RESULTS AND DISCUSSION 
 
Characterization of transgenic mice carrying the 
A34 mutant trsp transgene – Founder mice 
containing 1, 4 and 6 copies (heterozygous 
animals) of the A34 mutant transgene were 
generated as described in the Experimental 
Procedures. Each mouse line was bred to yield 
homozygous trsp transgenic animals and the 
resulting lines were characterized in parallel with 
transgenic mice carrying low and high copy 
numbers of wild type or G37 trspt transgenes (22). 
To determine the effects of A34 transgenes on 
selenoprotein biosynthesis, wild type and A34 
transgenic mice carrying 4 or 12 copies of mutant 
transgenes were labeled with 75Se and the resulting 
labeled selenoprotein population analyzed (Fig. 1). 
The highest A34 transgene copy number inhibited 
GPx1 expression, while TR1 expression showed 
little change in liver and kidney of both A34 
transgenic mice. Thus, the low copy A34 transgene 
number appeared to have only a minor effect on 
overall synthesis of selenoproteins. Similar 
observations were reported previously for the G37 
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transgene carrying similar trspt copy numbers 
(22). These data suggested that the mutations at 
position 34 and 37 in Sec tRNA[Ser]Sec, which both 
result in loss of Um34, had similar effects on the 
expression of selected selenoproteins.  
Replacement of housekeeping selenoproteins in 
liver – Mouse lines carrying the targeted removal 
of trsp in liver (Δtrsp) and carrying either A34, 
low or high copy G37 transgenes, or the wild type  
(trspt) transgenes were generated (See Table 1). 
Importantly, trsp is not expressed in liver, while it, 
along with each transgene, is expressed in all other 
organs and tissues. Thus, the effects of the 
transgene products on selenoprotein expression 
and function occur independently of the wild type 
gene only in the trsp targeted organ. Since the trsp 
and trspt mouse lines express wild type Sec 
tRNA[Ser]Sec and over-expression of trsp has little 
or no effect on selenoprotein synthesis 
(17,20,21,22,37), they both were considered as 
controls. Genotypes were determined in liver and 
kidney, as the affected and control organs, 
respectively, and the expected genotypes were 
found as shown in Fig. 2.  
     Attempts to restore the housekeeping 
selenoprotein population in liver of Δtrsp mice by 
mating with A34 transgenic mice carrying a higher 
copy number of A34 transgenes than the 2 copies 
used in replacing selenoprotein expression in these 
mice were unsuccessful. In addition, we were not 
able to rescue trsp null mice with any A34 
transgenic mice regardless of the transgene copy 
number. Furthermore, the number of matings to 
obtain restored selenoprotein expression in Δtrsp 
liver with the A34 transgene exceeded, by more 
than three-fold, those required to obtain the A37 
and trspt selenoprotein liver replacement mice. 
These findings and their implications are further 
discussed below in the section Consequences of 
A34 Sec tRNA[Ser]Sec in selenoprotein synthesis. 
  75Se-Labeling - The expression of selenoproteins 
in liver, kidney, testis, brain, heart and plasma of 
the six mouse lines was examined by labeling 
animals with 75Se and analyzing labeled proteins 
in tissue extracts following gel electrophoresis. 
Coomassie blue-stained gels of total proteins (Fig. 
3A, lower panels) from the different tissues served 
as loading controls and similar patterns and 
amounts of total proteins from the same tissues 
were observed with the possible exception of an 
enriched band indicated with an arrow in the liver 
Δtrsp extract. Identification of this band as 
glutathione S-transferase and its possible 
significance were reported elsewhere (27). 
Another protein band which migrated near 20 kDa 
was observed to vary in amounts in liver of mutant 
Sec tRNA[Ser]Sec mouse lines (see arrow with a 
question mark in lower liver panel in Fig. 3). This 
band did not vary reproducibly in livers from 
mutant trsp mice and therefore we have not 
identified it. 
     Variations were observed in the selenoprotein 
labeling patterns within organs and tissues of mice 
with the six different genotypes, particularly in 
liver between the two control mice containing wild 
type trsp and trspt and the four mouse lines 
containing the defective tRNAs[Ser]Sec (Fig. 3). 
Some 75Se-labeled bands have been previously 
identified, including TR1, GPx1, GPx4 and Sep15, 
which are indicated in the liver panel (23,27,33). 
SelW, indicated with a question mark, has been 
tentatively identified (see 27 and references 
therein). The band that migrates just below TR1 is 
likely selenophosphate synthetase 2 (SPS2), 
although SelP also migrates at this position (1). 
GPx3 and SelP, which are indicated in the plasma 
panel, have been characterized in plasma (27 and 
references therein).  
     The selenoprotein labeling patterns from trsp 
and trspt control mice (lanes 1 and 2, respectively, 
in each panel of Fig. 3) were similar with some 
minor differences. For example, GPx1 and GPx4 
appeared to be more enriched in kidney (control 
tissue), and liver of trspt mice than in the 
corresponding tissues in trsp mice. Comparison of 
mice encoding wild type trsp to those lacking trsp 
in liver (Δtrsp) showed that, as expected, most of 
the selenoprotein population is absent in Δtrsp 
liver. The minor selenoprotein bands observed in 
Δtrsp mice are likely proteins from liver cell types 
other than hepatocytes (27) which is the only cell 
type in which trsp deletion is targeted (28).  
     The presence of the A34 or G37 mutant 
transgenes in Δtrsp mice resulted in TR1 and 
GPx4, and possibly SelP and/or selenophosphate 
synthetase 2 (SPS2), being restored in liver. The 
selenoprotein-labeled population in kidney 
appeared to be similar in the four tRNA[Ser]Sec 
defective mouse lines with the possible exceptions 
of a reduced level of GPx1 in the high copy G37 
transgene line (Fig. 6) and the elevated levels of 
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GPx1 and 4 in Δtrsp. The higher number of 
transgenes in high copy G37 than A34 would also 
seem to account for the reduced amounts of GPx1 
observed in the other tissues. The G37 low copy 
number and A34 transgenes resulted in similar 
effects in labeling in the tissues examined except 
plasma. SelP, which is synthesized largely in the 
liver and transported to other tissues (see 15 and 
references therein), is reduced in plasma of A34 
and G37 mice and possibly in testes of these 
mouse lines compared to control mice. SelP is also 
reduced in plasma in Δtrsp mice compared to the 
two control mice, trsp and trspt. These 
observations are further considered below in the 
section on Consequences of A34 Sec tRNA[Ser]Sec in 
selenoprotein synthesis.  
     GPx4 also appeared to be slightly enriched in 
testes of several mouse lines compared to trsp 
mice. GPx levels were further examined by 
measuring GPx activity in each tissue of the six 
mouse lines (see GPx assays below and in Table 
1). 
     To examine the 75Se-labeling of TR1 in liver 
and kidney in more detail, TR1 was enriched from 
these tissues by passing tissue extracts over an 
ADP-Sepharose 4B affinity column (22). As 
shown in Fig. 4B, similar amounts of TR1 were 
present in both tissues of each mouse line with the 
exception of liver from Δtrsp mice which 
expressed TR1 poorly. In addition, TR1 appeared 
to be slightly enriched in kidney of Δtrsp mice and 
possibly in both tissues of trspt mice.  
  Northern blot analysis - Analysis of mRNA 
levels is an alternative means of examining the 
status of selenoprotein expression. The presence of 
UGA in the coding region targets some 
selenoprotein mRNAs for nonsense mediated 
decay (NMD; 34,35). As shown previously 
(34,35), NMD of some selenoprotein mRNAs is 
dependent on selenium status (see also reviews in 
17,36). GPx1 mRNA was present in low, but 
detectable levels, in liver of the four tRNA[Ser]Sec 
defective mice compared to those of the two 
control mouse lines (Fig. 4). The levels of SelW 
mRNA were reduced substantially in liver of the 
four tRNA[Ser]Sec defective mice and in reduced 
levels in kidney of A34 and high copy G37 
transgenic mice. SelT mRNA levels were reduced 
in liver of the four tRNA[Ser]Sec defective mice, but 
present in similar levels as control mice in kidney. 
SelR mRNA was reduced in liver of high copy 
G37 transgenic mice, but remained at similar 
levels in liver and kidney of the other mice with 
only slightly lower amounts in liver of the low 
copy G37 transgenic and Δtrsp mice. The level of 
SelK mRNA was similar in the mouse lines 
examined with the exception of a slightly reduced 
level in liver of Δtrsp mice. The mRNA levels of 
the other selenoproteins examined appeared to be 
present in similar amounts in both tissues of the 
six mouse lines or to vary only slightly in the four 
tRNA[Ser]Sec defective mice as compared to those of 
the controls. 
  Selenium status - The selenium levels were 
determined in liver, kidney, testes, brain and 
plasma (Table 2). The amounts of selenium were 
similar in each tissue of the trsp and trspt control 
mice with the exception of liver and kidney that 
appeared to have a somewhat higher selenium 
level in mice carrying the trspt transgene. The four 
defective tRNA[Ser]Sec mice had lower, but similar 
levels in liver, kidney and plasma compared to the 
two control mice, while A34 and the low copy G37 
transgenic mice had similar levels as the two 
controls in testes and brain. The high copy G37 
transgenic and Δtrsp mice had similar, but slightly 
lower selenium levels than the two other 
transgenic defective mice in testes.  
  Western blot analysis – The expression levels of 
several selenoproteins were further examined by 
Western blot analyses. Because GPx1, SelR and 
SelT were not rescued in an earlier study involving 
the G37 transgene (23,24), as assessed by Western 
blot analysis, we focused on these selenoproteins 
to determine whether they might be restored in 
liver by the A34 transgene. GPx4 expression was 
also examined since its 75Se-labeling patterns 
varied in liver and kidney within the different 
mouse lines (Fig. 3).  
     GPx1 was not detected in liver of Δtrsp mice, 
or in liver of mice carrying either the A34 or G37 
transgenes (Fig. 5). GPx1 was present in lower 
levels in kidney of Δtrsp, A34 and low copy G37 
transgenic mice than in the other mice, and was 
not detected in kidney from high copy G37 
transgenic mice. The relative amounts of GPx1 
were similar in kidney of Δtrsp and A34 mice, but 
less than observed in the low copy G37 transgenic 
mouse. Possible reasons for these differing levels 
of GPx1 expression are further considered below. 
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     GPx4 was present in liver of low copy G37 
transgenic mice and was virtually absent in liver 
from the other three tRNA[Ser]Sec defective mice. 
This selenoenzyme appeared to be reduced, but 
present in kidney of Δtrsp, A34 and low copy G37 
transgenic mice and virtually absent in high copy 
G37 transgenic mice. SelR was poorly expressed 
in liver of both G37 transgenic mouse lines 
relative to control mice, but slightly better 
expressed in A34 mice. SelR was also not 
expressed in kidney of the high copy G37 mice 
and weakly expressed in the other tRNA[Ser]Sec 
defective mice (Fig. 5), although SelR mRNA was 
expressed in this tissue (Fig. 4). Interestingly, SelT 
was not expressed in kidney of high copy G37 
mice and partially or poorly expressed in kidney or 
liver of the tRNA[Ser]Sec defective mice (Fig. 5) 
even though its mRNA appeared to be synthesized 
in sufficient levels within these tissues for 
adequate translation (Fig. 4). 
     The combination of reasonable mRNA levels 
with low protein levels strongly suggests that the 
defect in stress-related selenoprotein synthesis in 
the mutant trspt mice is in translation rather than 
via effects on mRNA stability. More specifically, 
these findings raise the possibility that NMD of 
selenoprotein mRNAs (34,35) results from a block 
to translation due to the absence of the Um34 
isoform. The corresponding mRNA with the 
encoded NMD criteria are then degraded. The site 
of regulation of mRNA decay may therefore be the 
Um34 methylation step that is known to be 
sensitive to selenium status (37). In fact, the Um34 
isoform is dramatically reduced during selenium 
deficiency leading us to speculate that phenotypes 
displayed by the A34 and G37 transgene lines 
(Northern data shown in Fig. 4 and Western data 
shown in Fig.5) likely mimic those provoked by 
selenium-deficient conditions, thus pinpointing 
this phenomenon as a failure of mRNA translation 
by the Um34 isoform. 
  Glutathione peroxidase and TR1 activities – 
Since the labeling of GPx1 and GPx4 with 75Se 
appeared to be enhanced in kidney of trspt, Δtrsp, 
A34 and low copy G37 mice (Fig. 3), but their 
levels were diminished in this tissue as assessed by 
Western blotting (Fig. 5), we examined the 
cytosolic GPx activities in kidney and several 
other tissues from the six mouse lines (Table 3, 
Expt I). The assay did not distinguish between the 
different peroxidases but reveals whether total 
GPx activity was increased or decreased. In liver, 
where most of the GPx activity is due to GPx1, the 
activities were similar in the two control mice, trsp 
and trspt, but extremely low in Δtrsp mice and 
Δtrsp mice carrying either the A34 or G37 
transgene. In the other tissues examined, GPx 
levels were also similar in the two control mice. 
However, non-liver tissues of the four tRNA[Ser]Sec 
defective mouse lines had variable amounts of 
GPx activity. For example, in kidney, GPx 
activities were reduced in the Δtrsp mice or mice 
carrying A34 and low copy G37 transgenes, but 
were even lower in mice carrying the high copy 
G37 transgene. Testes and brain had normal GPx 
activities in the Δtrsp mice, whereas mice 
encoding the A34 and low copy G37 transgenes 
had reduced activities, and those encoding the high 
copy G37 transgene had even lower levels. Plasma 
had low and similar activity levels in the four 
defective tRNA[Ser]Sec mouse lines, although the 
levels in low copy G37 mice appeared to be 
slightly higher. Thus, the mutations in trsp did not 
support full GPx1 activities. In particular, the high 
copy G37 transgene apparently exerted dominant 
negative effects in kidney and brain even in the 
presence of wildtype trsp alleles, since GPx 
activities in high copy G37 mutants were below 
the levels in Δtrsp mutants. These observations 
appear to exclude simple effects due to impaired 
selenium transport to these tissues. 
     Interestingly, GPx activities in kidney of Δtrsp 
mice were lower than in control mice even though 
kidney was not the targeted tissue (Table 3). We 
have proposed that this is a result, at least in part, 
of reduced selenoprotein P (SelP) expression and 
thus impaired selenium transport of SelP from 
Δtrsp liver to kidney (15). The selenium levels 
observed in kidney in the present study were lower 
in Δtrsp mice than control mice (Table 2). This 
result seems to conflict with a previous study with 
the same mouse lines (27), but gender differences 
likely explain this apparent conflict. In the present 
report, male mice were analyzed, while in the 
earlier study, female mice were studied (27). We 
have recently described lower selenium levels and 
GPx activities in mutant kidneys from male Δtrsp 
mice (15). Since gender-differences were observed 
in these experiments and female Δtrsp mice were 
less affected than male mutants (U.Schweizer, 
unpublished data), the gender-specific differences 
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in expression of prototype selenoenzymes in major 
organs of the mouse were systematically explored 
(38,39). GPx and deiodinase type I activities were 
higher in female kidney compared to male kidney, 
while hepatic deiodinase type I activity was higher 
in male compared to female mice. Since GPx 
activity is a good indicator of tissue selenium 
content, it would seem that the reduced selenium 
level detected in kidney of Δtrsp mice compared to 
that of control mice (Table 2) may account in part 
for the lower GPx activities found in Δtrsp mice, 
while an additional dominant negative effect of 
high copy G37 further reduced kidney GPx 
activity. It should also be noted that the 
observation of gender differences with respect to 
selenium metabolism in rodents is not a recent 
one. For example, Burk and collaborators found 
that male rats were more affected by selenium 
deficiency than female rats and the nutritional 
requirement for selenium is higher in males than 
females (40). 
    The Western blot analysis of GPx1 and GPx4 in 
liver and kidney (Fig. 5) were in closer agreement 
with the direct GPx enzyme assays (Table 1, Expt 
1) than with the 75Se-labeling data (Fig. 3). This 
discrepancy almost certainly reflects variations in 
both selenoprotein pool sizes and turnover rates 
that would influence patterns of 75Se-labeling. In 
addition, the A34 tRNA[Ser]Sec isoform may also 
insert Sec in place of Cys in response to certain 
Cys codons, UGU and UGC, that would also 
affect labeling patterns as well as the activity and 
Western blot analysis (see section below on 
Consequences of A34 Sec tRNA[Ser]Sec on 
selenoprotein synthesis). 
     TR1 assays were also carried out in liver and 
kidney of the six mouse lines (Table 3, Expt II). 
TR1 activities were similar in kidney of each 
mouse line except in high copy G37 which was 
about half that of controls. In liver, Δtrsp had low, 
detectable activity which was likely due, for the 
most part, to liver cell types other than hepatocytes 
(27). TR1 activity was recovered with the three 
mutant transgenes, but low copy G37 was slightly 
less than controls, high copy G37 about half that 
of controls and A34 slightly less than that of low 
copy G37. 
Fractionation, sequencing and codon recognition 
of T34->A34 Sec tRNA[Ser]Sec - The Sec tRNA[Ser]Sec 
population was examined in liver from five of the 
six mouse lines. The low copy G37 transgenic 
mouse was excluded because it had been 
examined previously (27). The endogenous wild 
type Sec tRNA[Ser]Sec was absent in liver of Δtrsp 
mice (data not shown) which allowed us to 
examine the A34 mutant tRNA population without 
any influence of host wild type tRNA. Total tRNA 
was isolated from liver of the five mouse lines, 
aminoacylated with 3H-serine and the resulting 3H-
seryl-tRNA isoforms chromatographed over a 
RPC-5 column. The elution profile of the 
tRNA[Ser]Sec population from the A34 replacement 
mouse is shown in Figure 6. The mutant tRNA 
eluted from the column as two major peaks. A 
small aliquot of two fractions from each peak was 
taken for sequencing, while the remainder of each 
peak was pooled for coding studies. The codon 
recognition properties of Peak I demonstrated that 
it decoded UGU, UGC and UGA (Fig. 6) 
suggesting that the anticodon was ICA. Peak II 
decoded UGU suggesting that its anticodon was 
ACA. Sequences of two separate fractions of Peak 
I showed that the base in the wobble position was 
G, which corresponds to I in the actual sequence 
(31). The anticodon was therefore ICA. Sequences 
of the two fractions of Peak II demonstrated that 
the base in the wobble position was A and the 
anticodon was ACA. The distributions of Peaks I 
and II were 66.6 and 33.4%, respectively. The 
elution profiles of 3H-seryl-tRNA[Ser]Sec from the 
other mouse lines, with the exception of that from 
the Δtrsp mouse line, are shown in the inset in 
Figure 6.  
  Um34 is important for stress-related 
selenoprotein expression – The A34 and G37 
mutations result in the loss of highly modified, but 
very different bases, mcm5U in A34 and i6A in 
G37. The common feature of these mutant tRNAs 
is that they lack Um34. The two tRNAs are clearly 
capable of decoding Sec UGA codons as both 
support selenoprotein synthesis in mouse liver 
lacking wild type Sec tRNA[Ser]Sec (see Figs. 3 and 
5), but neither is able to restore stress-related 
selenoprotein synthesis in liver following trsp 
knockout (Fig. 5). Although minor differences 
were observed in mRNA stability of certain 
selenoprotein mRNAs and in levels of certain 
selenoproteins, the overall effects of both mutant 
tRNAs were similar providing strong evidence that 
the Um34 Sec tRNA[Ser]Sec isoform is responsible 
for stress-related selenoprotein synthesis. The 
minor differences in the effects of the two tRNAs 
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on selenoprotein synthesis are likely due to the 
loss of the large, highly modified base in each 
mutant tRNA. Furthermore, the fact that selenium 
deficiency in rodents mimics the effects of the two 
Um34 lacking tRNAs in that the level of the 
Um34 Sec tRNA[Ser]Sec isoform and the expression 
of stress-related selenoproteins are reduced 
(reviewed in reference 17) also provides strong 
support that this isoform is indeed responsible for 
stress-related selenoprotein synthesis.  
     How does the Um34 Sec tRNA[Ser]Sec isoform 
regulate stress-selenoprotein synthesis? We 
examined many of the more likely features that 
might be expected to play a role in the selective 
expression of selenoproteins by the Um34 isoform 
(37). These included nucleotide context of the 
UGA Sec codon, the total length of the cDNA 
coding region, the number of exons within the 
gene, the exon within the gene wherein the UGA 
resides, the number of nucleotides between the 
UGA Sec codon and the stop codon, the number of 
nucleotides between the stop codon and the highly 
conserved AUGA sequence within the SECIS 
element, and the number of nucleotides between 
the highly conserved AUGA sequence within the 
SECIS element and the downstream poly A signal. 
We concluded that none of these components are 
likely involved. Remaining candidates for 
mediating the effects of Um34 include the 
uncharacterized Um34 methylase and/or different 
SECIS-binding proteins. Interestingly, a new 
SECIS-binding protein that preferentially binds to 
different selenoprotein mRNAs has been detected 
(D. Driscoll, personal communication). We are 
currently working to identify and characterize the 
Um34 methylase. 
  Consequences of A34 Sec tRNA[Ser]Sec on 
selenoprotein synthesis –  Although the anticodon 
in the A34 tRNA[Ser]Sec was changed to decode Sec 
as well as Cys codons, the 75Se-labeling studies 
showed that only natural selenoproteins were 
labeled with 75Se. The two tRNA[Ser]Sec isoforms, 
tRNA[Ser]SecICA and ACA, apparently do not replace 
Cys in the general protein population, likely 
because tRNA[Ser]Sec associates with a specific 
elongation factor (EFsec) rather than EF-1alpha. 
However, both mutant tRNAs have the potential to 
translate Cys codons, UGU and UGC, with a 
preference for UGU (see Fig. 6). The 
demonstrated ability of tRNA[Ser]SecICA to translate 
UGA (Figs. 3 and 5) indicates that it utilizes the 
Sec decoding machinery (i.e., SECIS elements 
(41) and EFsec (42,43)) which are required for 
incorporation of Sec into protein. These mutant 
tRNAs probably insert Sec at some Cys codons in 
selenoprotein mRNAs with insertion governed by 
the same criteria that control Sec insertion at UGA 
(location of the Sec UGA codon relative to the 
SECIS element, for example, 44,45). These tRNAs 
would likely compete with tRNACys for decoding 
specific Cys codons. 
     Replacement of Cys with Sec in selenoproteins 
would most likely result in lower enzymatic 
activity as is found in the GPxs in the mutant 
tRNA lines (Table 3). That the level of SelP was 
severely reduced in the presence of the A34 
transgene (see plasma panel in Fig. 3) supports the 
idea of competition, but also may indicate that a 
protein with multiple amino acid replacements is 
more rapidly degraded and/or poorly transported. 
Clearly, SelP has multiple Sec and Cys residues 
and the repeated use of a Sec tRNA[Ser]SecICA and/or 
ACA would likely result in reduction in overall SelP 
expression.  
    Competition of Cys and Sec codons for 
tRNA[Ser]Sec may explain the inability to rescue trsp 
null mice with any A34 transgenic mouse 
regardless of the transgene copy number even 
though the same breeding scheme successfully 
rescued trsp null mice using wild type or G37 
transgenic mice (23,24). We were able to restore 
selenoprotein expression in liver of mice targeted 
for removal of Δtrsp with A34 transgenic mice 
carrying two copies of the mutant transgene, but 
not with higher copy numbers employing the same 
breeding scheme as that which replaced 
selenoprotein expression with trspt and G37 
transgenes. Sec tRNA[Ser]Sec isoforms with 
anticodons ACA and ICA may compete more 
effectively with Cys tRNA in decoding 
selenoprotein mRNAs and insert Sec in place of 
Cys disrupting function and resulting in lethality. 
Although high copy numbers were tolerated by 
A34 transgenic mice, these animals also had wild 
type trsp.  
  Significance of developing novel mouse models – 
Selenium is reported to have many health benefits 
including roles in preventing cancer, heart disease 
and other cardiovascular diseases, in delaying the 
aging process and the onset of AIDS in HIV 
positive patients, male fertility, immune function, 
mammalian development and viral inhibition (46). 
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Numerous large-scale, human clinical trials have 
been undertaken to examine the effect of selenium 
in preventing the onset of disease with most 
focusing on the effects of selenium in cancer 
prevention. These trials are very costly and were 
designed with little understanding of how 
selenium acts at the molecular level. Development 
of animal models to elucidate the metabolic roles 
of selenium, selenoproteins and low molecular 
weight selenocompounds is essential to 
understanding roles of selenium in health and 
development and in designing better human 
clinical trials. For example, recent evidence 
suggests that selenium may be ambivalent in its 
metabolic action in cancer in that it has cancer 
chemopreventive activity through some 
selenoproteins, but once a malignancy begins, 
selenium also promotes growth through 
selenoprotein TR1 (47,48). Furthermore, it is 
possible that the outcome of selenium 
supplementation at the doses used in human 
clinical trials may depend on individual genotypes, 
disease states and other factors that can be 
elucidated through animal models. 
     We have therefore generated several mouse 
models to provide a better understanding of the 
role of selenium, selenoproteins and low 
molecular weight selenocompounds in health and 
development. Our transgenic mouse model 
employing high copy G37 transgenic mice has 
been used to show that both selenoproteins and 
low molecular weight selenocompounds have a 
role in preventing colon cancer (49) and 
selenoproteins have a role in preventing prostate 
cancer (50). This model has also been used to 
examine other aspects of the role of selenoproteins 
in health (51,52). Our floxed trsp model using 
loxP/Cre technology allowing targeted removal of 
trsp in specific tissues or organs has been used to 
show that selenoproteins play a role in endothelial 
development and heart disease prevention (26), 
proper liver function (27), neuronal function 
(Schweizer et al, submitted for publication) and in 
skin function and development (unpublished data).  
     The above useful models are surpassed by the 
one presented here which allows alteration of the 
selenoprotein population in liver with wild type or 
mutant trsp transgenes. These mice are 
phenotypically normal, allowing study of the role 
of selenium, housekeeping selenoproteins and 
stress-related selenoproteins as well as the entire 
selenoprotein population in resistance to various 
factors, such as toxic metabolites, 
hepatocarcinogens and liver cancer driver genes. 
The approach of targeting specific tissues for trsp 
removal can be used to generate other model 
systems for studying the role of selenium and 
selenoproteins in tissues of interest. The 
possibility that the expression of G37 and A34 
mutant tRNAs[Ser]Sec in all tissues and organs may 
hinder experimentation seems not to be an issue. 
The high copy G37 transgenic mouse, which 
expresses G37 tRNA in all tissues and organs, has 
been used to show that selenoproteins and low 
molecular weight selenocompounds have a role in 
colon cancer prevention (49) and selenoproteins in 
prostate cancer prevention (50). The major 
advantage of the current model is that we can 
target the removal of trsp and then replace or 
partially replace the selenoprotein population. The 
targeted mouse models presented in this study are 
amongst the most sophisticated mouse models 
developed to date for studying the role of 
selenium, selenoproteins and low molecular 
weight selenocompounds in health and 
development.      
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FIGURE LEGENDS 
 
Fig. 1. 75Se-Labeling of selenoproteins in A34 transgenic mice. Two of the A34 transgenic mouse lines 
encoding four copies of mutant transgenes (heterozygous animals containing a single allele with four 
copies) and encoding 12 copies of the mutant transgenes (homozygous animals containing two alleles 
with six copies/allele) were labeled with 75Se, protein extracts prepared from liver and kidney and 
electrophoresed. Gels were stained with Coomassie blue to assess the total protein population (see lower 
panels) and 75Se-labeled proteins detected using a PhosphorImager (see upper panels). Molecular weights 
of the protein markers are shown on the left of the panels and selenoprotein identity is indicated on the 
right by arrows (see also references 22, 27 and 33 for identification of selenoproteins, and Fig. 3 and its 
legend). Details of the 75Se-labeling experiments are given in Experimental Procedures. 
 
Fig. 2. Genotyping of mouse strains. DNA was isolated from liver and kidney of the 6 mouse lines (Table 
1) and PCR products (indicated on the left of the figure) were generated with the primers (indicated on the 
right) as described in Experimental Procedures. PCR of trspfl (wild type floxed gene) yielded a 1180 bp 
fragment, of trsp, (wild type gene) a 980 bp fragment, of Δtrsp (knocked out gene), a 500 bp fragment, of 
trspt, A34 or G37 (either wild type, A34 or G37 transgene), a 1072 bp fragment, and of AlbCre (Alb 
promoter controlling expression of the Cre recombinase gene), a 370 bp fragment (see also 27). 
 
Fig. 3.  75Se-Labeling of selenoproteins. A) The six mouse lines were labeled with 75Se.  Protein extracts 
were prepared from liver, kidney, testes, brain, heart and plasma, and treated as described in the legend to 
Figure 1. Molecular weights of the protein markers are shown on the left of the panels and selenoproteins 
are indicated on the right by arrows. Selenoprotein identifications are based on references 22, 27 and 33. 
The arrows in the Coomassie Blue stained gel in the lower liver panel indicate glutathione S-transferase, 
GST, identified in an earlier study (27) and an unidentified protein (indicated with a question mark) that 
varied inconsistently in amounts in liver of the mutant trspt transgenic mice (see text). During preparation 
of plasma from trsp and Δtrsp mice, greater hemolysis of the red blood cells occurred which accounted 
for the globin observed in the Commassie Blue stained gels (see lanes 1 and 6 in the Plasma panel). B) 
75Se-labeled TR1 was purified from crude extracts of liver and kidney using ADP Sepharose 4B prior to 
gel electrophoresis as described in Experimental Procedures. Partially purified 75Se-labeled TR1 from the 
two organs is shown. 
 
Fig. 4. Northern blot analysis. RNA was extracted from liver and kidney of the six mouse strains and 
electrophoresed. RNA was then transblotted onto the appropriate membrane and hybridized with the 
indicated probes. Relative labeling was assessed using a PhosphorImager as described in Experimental 
Procedures. Staining of developed gels with ethidium bromide showed that identical amounts of 18s and 
28s rRNA were present in all tissue extracts (loading control, data not shown). Each of the Northerns 
shown was carried out separately on two occasions with tissues from different mice with similar results. 
SelK mRNA was not examined in liver and kidney of low copy G37 mice as the levels of SelK mRNA 
from both A34 or high copy G37 mice were very similar. 
 
Fig. 5. Western blot analysis. Protein extracts were prepared from liver and kidney from the six mouse 
lines and electrophoresed. Protein was then transblotted onto the appropriate membrane and treated with 
the appropriate antibodies as described in Experimental Procedures. Selenoproteins are labeled on the left 
of each panel. 
 
Fig. 6. Fractionation, sequencing and codon recognition studies. Transfer RNA was isolated from five 
mouse lines (A34, high copy G37, and trspt transgenic mice, and trsp and Δtrsp mice), aminoacylated 
with 3H-serine and the resulting 3H-seryl-tRNAs chromatographed on a RPC-5 column as described in 
Experimental Procedures. The graph shows 3H-seryl-tRNA[Ser]Sec from the A34 mouse line, the arrows 
indicate the fractions from which small aliquots of the two peaks were taken for sequencing and ICA and 
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ACA show the anticodon sequences determined from sequencing these samples. The hatched areas show 
the fractions pooled for coding studies which were carried out using 10,000 total cpm of Peak I/assay 
wherein the cpm bound to ribosomes in the absence of codon were 1,170, and using 10,000 total cpm of 
Peak II/assay wherein the cpm bound to ribosomes in the absence of codon were 1,452. CPM bound to 
ribosomes in the absence of codon were subtracted from the cpm bound in the presence of codon and 
given as ΔCPM Bound. The inset shows the corresponding 3H-seryl-tRNA[Ser]Sec isoforms from the other 
four mouse lines and the relative cpm at the highest point of each peak. The fraction numbers of each 
highest point shown in brackets were: G37, 14,010 cpm [19]; trsp, 5,065 cpm [49]; and trspt, 37,805 cpm 
[44]. The distributions of the two isoforms were determined as described previously (22):  ICA and ACA 
were present at 66.6% and 33.4% respectively. 
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TABLE 1. Summary of breeding schemes for generating experimental mouse linesa,e 
 
 
 
Matingsa 
Wild 
typeb,c  
Wild type 
replacement b,c 
(20 copies) 
A34 
transgenicc 
(2 copies) 
G37 
transgenicc 
(2 or 16 
copies)d 
Δtrsp 
knockoutc 
1st  breeding 
trsp+/+ 
X 
trspfl/+-
AlbCre+/+ 
trspt/t 
X 
trspfl/+-AlbCre+/+ 
trsp+/+-A34t/t 
X 
trspfl/+-AlbCre+/+ 
trsp+/+-G37t/t 
X 
trspfl/+-AlbCre+/+ 
trspfl/fl 
X 
trsp+/+-
AlbCre+/+ 
F1  
(2nd breeding) 
trsp+/+- 
AlbCre+/- 
X 
trsp+/+-
AlbCre+/- 
trspfl/+-AlbCre+/--
trspt/- 
X 
trspfl/+-AlbCre+/--
trspt/- 
trspfl/+-AlbCre+/--
A34t/- 
X 
trspfl/+-AlbCre+/--
A34t/- 
trspfl/+-AlbCre+/--
G37t/- 
X 
trspfl/+-AlbCre+/--
G37t/- 
trspfl/+-AlbCre+/-  
X 
trspfl/+-AlbCre+/-
F2 
(experimental 
mice)e 
trsp+/+-
AlbCre+/+ 
trspfl/fl-AlbCre+/+-
trspt/t 
trspfl/fl-
AlbCre+/+-A34t/t 
trspfl/fl-
AlbCre+/+-G37t/t 
trspfl/fl-
AlbCre+/+ 
Designationf trsp trspt A34 G37 ∆trsp 
aMatings to obtain each mouse line used in this study are shown in the table.  
bBoth wild type mice, designated trsp in the text, and wild type selenoprotein replacement mice, designated trspt in 
the text, were used as control mice. 
cGenotype designations denote the following: trsp+ (wild type Sec tRNA[Ser]Sec gene), trspfl (floxed Sec tRNA[Ser]Sec 
gene); trspt (Sec tRNA[Ser]Sec transgene); Δtrsp (liver trsp knockout); AlbCre (albumin Cre gene); A34 (A34 mutant 
transgene); and G37 (G37 mutant transgene). Homozygous genotypes and the corresponding heterozygous 
genotypes are designated as follows: trsp+/+ and trsp+/- (wild type Sec tRNA[Ser]Sec gene); trspfl/fl and trspfl/+ (floxed 
Sec tRNA[Ser]Sec gene); trspt/t and trspt/- (wild type Sec tRNA[Ser]Sec transgene); AlbCre+/+  and AlbCre+/- (albumin Cre 
gene); A34t/t and A34t/- (A34 transgene); and G37t/t and G37t/- (G37 transgene).  
dG37 transgenic mice carrying 2 or 16 copies of the transgene are referred to in the text as G37 low copy number or 
G37 high copy number, respectively. 
eExperimental mice are those animals generated from the matings for use in the study.  
fThe genotypes shown in the F2 experimental mice are designated in the text as: trsp or wild type control mouse; 
trspt or wild type replacement mouse which is also a control mouse; A34 transgenic mouse; G37 transgenic mouse; 
Δtrsp or liver knockout mouse. 
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TABLE 2. Selenium levels in tissues of liver replacement mice 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Selenium levels (ppm)a 
Tissue trsp trspt A34 G37 low G37 high Δtrsp 
Liver 1.40 1.66 0.37 0.43 0.43 0.41 
Kidney 1.27 1.50 0.86 1.02 0.63 0.95 
Testes 0.81 0.85 0.80 0.78 0.69 0.69 
Brain 0.19 0.17 0.16 0.15 0.09 0.16 
Plasma 0.40 0.34 0.10 0.17 0.10 0.09 
aSelenium levels were measured as described in Experimental Procedures. Each assay was 
carried out in duplicate and values represent the average of at least two different mice of each 
genotype. 
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TABLE 3. Glutathione peroxidase and TR1 activities 
 
   Enzyme activitiesa 
Expt Enzyme Tissue trsp trspt A34 G37 low G37 high Δtrsp 
I GPx Liver 468.4 +48.1 438.4 +54.4 3.8 +1.2 65.3 +11.7 29.2 +2.0 29.0 +10.2 
 GPx Kidney 364.7 +27.2 373.6 +12.5 118.2 +38.9 194.6 +33.8 61.5 +10.3 163.4 +18.7 
 GPx Testes 20.3 +1.2 21.8 +0.5 14.3 +2.0 10.4 +0.7 7.6 +0.5 20.9 +1.4 
 GPx Brain 15.5 +2.0 18.7 +0.2 11.5 +3.1 16.2 +0.8 6.6 +0.4 14.8 +0.9 
 GPx Plasma 1369.0 +133.3 1594.0 +135.8 521.1 +7.6 731.6 +173.3 405.0 +55.8 490.4 +105.0 
II TR1 Liver 1.05 + 0.12 1.02 +0.05 0.74 +0.07 0.90 +0.11 0.46 +0.08 0.25  +0.08 
 TR1 Kidney 1.11 + 0.07 1.19 + 0.18 1.10 + 0.03 1.01 + 0.07 0.57 + 0.08 1.25 + 0.06 
aGlutathione peroxidase (Experiment I) and TR1 activities (Experiment II) were measured in 
mice as given in Experimental Procedures. Each assay was carried out in triplicate. Values 
expressed are nmol NADPH/min/mg protein or nmol NADPH/min/ml plasma for glutathione 
peroxidase activity and ∆A412/mg protein for TR1 activity. 
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